Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
BMC Cancer ; 19(1): 1021, 2019 Oct 29.
Artigo em Inglês | MEDLINE | ID: mdl-31664946

RESUMO

BACKGROUND: Recent preclinical data suggest that androgen receptor (AR) signaling plays a significant role in subsets of breast cancer. Clinical trials testing AR-targeting therapies in breast cancer have been conducted. Assessment of AR-signal in breast cancer tissue maybe useful for treatment selections. Prostate specific antigen (PSA) is the product of an androgen-responsive gene. Serum PSA (sPSA) can be detected in women by a highly sensitive assay although the concentration is much lower than that observed in males. We investigated if sPSA reflects tumor biology, including AR signaling in breast cancer patients. METHODS: In this study, 132 healthy controls and 144 breast cancer patients were enrolled. sPSA was evaluated by the chemiluminescent enzyme immunoassay (CLEIA) method. Correlations between sPSA and the various clinicopathological factors were analyzed. RESULTS: In post-menopausal state, sPSA detection rate was significantly higher in breast cancer patients compared with controls (27.4% vs 11.3%: p = 0.0090), but not in the whole cohort (29.2% vs 25.8%: p = 0.5265) or pre-menopausal subgroup (37.0% vs 42.6%: p = 0.6231). In post-menopausal breast cancer cases, higher sPSA value was associated with clinic-pathological factors including the expression of AR protein in primary legion. In a correlation analysis of quantitative data limited to post-menopausal metastatic breast cancer (MBC), sPSA was positively, albeit weakly correlated with clinic-pathological features including serum testosterone levels and AR positivity. CONCLUSIONS: Our data suggest that sPSA may reflect tumor biological properties including AR activity in post-menopausal breast cancer.


Assuntos
Neoplasias da Mama/sangue , Neoplasias da Mama/patologia , Calicreínas/sangue , Antígeno Prostático Específico/sangue , Adulto , Idoso , Antineoplásicos Hormonais/uso terapêutico , Biomarcadores Tumorais/sangue , Neoplasias da Mama/tratamento farmacológico , Estudos de Coortes , Feminino , Humanos , Técnicas Imunoenzimáticas/métodos , Pessoa de Meia-Idade , Pós-Menopausa/sangue , Receptores Androgênicos/metabolismo , Testosterona/sangue
2.
Surg Laparosc Endosc Percutan Tech ; 24(6): 537-41, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24710252

RESUMO

PURPOSE: The aim of this small study was to assess the clinical outcomes of self-expanding metallic stent (SEMS) placement followed by 1-stage laparoscopic resection for treatment of acute right-sided colonic obstruction due to carcinoma. METHOD: From January 2012 to December 2012, we performed 1-stage laparoscopic colectomy after placement of SEMS for right-sided obstructive colon carcinoma in 4 patients. RESULTS: SEMS placement was technically successful in all cases and symptoms were immediately relieved. The presence of the endoluminal stent did not prevent a laparoscopic approach; moreover, decompression of the bowel obstruction provided a wide field of view and working space for the laparoscopic procedure. There were no cases of conversion to laparotomy and no intraoperative complications. CONCLUSION: One-stage laparoscopic surgery, as a minimally invasive therapy, can be safely performed by SEMS placement in patients with acute right-sided colonic obstruction due to carcinoma. A large sample study is required to confirm the efficacy of this procedure.


Assuntos
Neoplasias do Colo/cirurgia , Obstrução Intestinal/cirurgia , Laparoscopia/métodos , Stents , Idoso , Feminino , Humanos , Longevidade , Masculino , Pessoa de Meia-Idade , Duração da Cirurgia , Resultado do Tratamento
3.
Int J Clin Exp Pathol ; 6(7): 1427-31, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23826426

RESUMO

We report a rare case of recurrent retroperitoneal dedifferentiated liposarcoma with osteosarcomatous components. An 82-year-old male diagnosed with recurrent retroperitoneal liposarcoma underwent a tumor resection. Histologically, osseous matrix with osteoid and mature hyaline cartilaginous tissues with high cellularity were observed in a fibrous background through most of the tumor, and scattered MDM2- and CDK4-positive atypical hyperchromatic stromal cells were detected surrounding the dedifferentiated areas. Dedifferentiation occurs in up to 10% of well-differentiated liposarcomas, frequently resembling a malignant fibrous histiocytoma-like pleomorphic sarcoma. In contrast, divergent differentiation with osteosarcomatous components is considered to be extremely rare.


Assuntos
Desdiferenciação Celular , Lipossarcoma/patologia , Recidiva Local de Neoplasia/patologia , Osteossarcoma/patologia , Neoplasias Retroperitoneais/patologia , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/análise , Quinase 4 Dependente de Ciclina/análise , Humanos , Imuno-Histoquímica , Lipossarcoma/química , Lipossarcoma/cirurgia , Masculino , Recidiva Local de Neoplasia/cirurgia , Osteossarcoma/química , Osteossarcoma/cirurgia , Valor Preditivo dos Testes , Proteínas Proto-Oncogênicas c-mdm2/análise , Reoperação , Neoplasias Retroperitoneais/química , Neoplasias Retroperitoneais/cirurgia , Resultado do Tratamento
4.
Endocr Pathol ; 4(3): 169-173, 1993 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32370431

RESUMO

A surgically treated idiopathic giant-cell granuloma of the pituitary in a 48-year-old man is described. Relative to previously reported cases, this case was unusual both clinically and histologically. Diabetes insipidus was the initial, and a prominent clinical, manifestation. Histological studies showed caseating granuloma or fibrosis in addition to a typical giant-cell granuloma. This is the first published documentation of the association of caseous necrosis in a patient diagnosed as having idiopathic giant-cell granuloma of the pituitary.Endocr Pathol 4:169-173, 1993.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA